title: How can proteomics elucidate the complexity of multiple sclerosis?
abstract: Multiple sclerosis affects more than 2.5 million people worldwide. Although multiple sclerosis was described almost 150 years ago, there are many knowledge gaps regarding its etiology, diagnosis, prognosis, and pathogenesis. Multiple sclerosis is an inflammatory, demyelinating, neurodegenerative disease of the CNS. During the last several decades, experimental models of multiple sclerosis have contributed to our understanding of the inflammatory disease mechanisms and have aided drug testing and development. However, little is known about the neurodegenerative mechanisms that operate during the evolution of the disease. Currently, all therapeutic approaches are primarily based on the inflammatory aspect of the disease. During the last decade, proteomics has emerged as a promising tool for revealing molecular pathways as well as identifying and quantifying differentially expressed proteins. Therefore, proteomics may be used for the discovery of biomarkers, potential drug targets, and new regulatory mechanisms. To date, a considerable number of proteomics studies have been conducted on samples from experimental models and patients with multiple sclerosis. These data form a solid base for further careful analysis and validation.
authors.affiliation: Neuroimmunomodulation Group and Neuroimmunology Unit, Department of Genetics, Evolution and Bioagents, University of Campinas, Campinas, São Paulo, Brazil.
authors.forename: Alessandro S
authors.initials: AS
authors.lastname: Farias
authors.affiliation: Neuroimmunomodulation Group and Neuroimmunology Unit, Department of Genetics, Evolution and Bioagents, University of Campinas, Campinas, São Paulo, Brazil.
authors.forename: Leonilda M B
authors.initials: LM
authors.lastname: Santos
mesh_terms: D000818:Animals; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000378:metabolism / Q000473:pathology; D006801:Humans; D009103:Multiple Sclerosis / Q000378:metabolism* / Q000473:pathology; D019636:Neurodegenerative Diseases / Q000378:metabolism / Q000473:pathology; D040901:Proteomics / Q000379:methods*
keywords: Experimental autoimmune encephalomyelitis; Inflammation; Multiple sclerosis; Neurodegeneration; Proteomics